炎症刺激诱导眼部补体激活及动物模型中眼内抑制补体因子D
本研究在小鼠和兔子中观察了Toll样受体配体、玻璃体腔注射或角膜清创等炎症刺激对眼部补体激活的影响,并评估了补体因子D(FD)中和抗体的眼内抑制作用。结果显示全身TLR刺激和眼组织损伤诱导眼内时间依赖的替代补体途径激活,衰老过程中眼补体水平也逐渐升高;兔玻璃体腔注射抗FD抗体可有效抑制脂多糖诱导的眼后段补体激活。
要点
- 全身TLR4配体脂多糖(LPS)腹腔注射后眼内C3和因子B(FB)的mRNA及蛋白水平升高。
- C3-/-和Cfb-/-小鼠中LPS诱导的补体激活产物显著减少。
- 兔玻璃体腔注射抗FD抗体抑制眼后段LPS诱导的补体激活,但眼前段和血浆未受抑制。
核心结论
- 全身TLR刺激和眼组织损伤诱导眼内时间依赖的替代补体途径激活,衰老过程中眼补体水平也逐渐升高。
- 抗FD抗体玻璃体腔注射可有效抑制兔眼后段LPS诱导的补体激活。
研究设计与样本
- 动物实验:小鼠接受TLR配体处理、玻璃体腔注射或角膜清创,检测补体蛋白和mRNA水平。
- 兔经静脉注射LPS后玻璃体腔注射FD中和抗体。
主要发现
- 小鼠腹腔注射TLR4配体LPS后眼内C3和FB的mRNA及蛋白水平升高,眼组织和血浆中C3和FB分解产物水平增加。
- C3-/-和Cfb-/-小鼠接受LPS刺激后补体激活产物显著减少。
- 小鼠全身给予TLR2和TLR3配体、玻璃体腔注射损伤或角膜清创后眼补体水平也升高,正常衰老过程中亦如此。
- 兔玻璃体腔注射抗FD抗体抑制眼后段LPS诱导的补体激活,但眼前段和血浆中未受抑制。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Genome-wide association studies suggest a role for the complement system in age-related macular degeneration (AMD). We characterized ocular complement activation and evaluated a complement factor D (FD) neutralizing antibody. METHODS: Mice were treated with toll-like receptor (TLR) ligands, intravitreal injection (IVT), or corneal debridement. Levels of complement proteins and mRNA were measured. A FD neutralizing antibody was administered IVT into eyes of rabbits that were challenged with LPS (lipopolysaccharide) administered intravenously. RESULTS: Levels of C3 and factor B (FB) mRNA and protein in the eye were increased following intraperitoneal injection of TLR4 ligand LPS. Increased levels of C3 and FB breakdown products were observed in both eye tissues and plasma. Complement activation products were markedly reduced in C3-/- and Cfb-/- mice challenged with LPS. Ocular complement levels were also elevated in mice treated systemically with TLR2 and -3 ligands, injured by IVT injection or corneal debridement, or even in normal aging. IVT administration of a complement FD neutralizing antibody in rabbits inhibited LPS-induced complement activation in the posterior segment of the eye, but not in the anterior segment of the eye or in plasma. CONCLUSIONS: Systemic TLR stimulation and eye tissue injury induced time-dependent alternative complement pathway activation in the eye. Ocular complement levels were also gradually elevated during aging. An anti-FD antibody IVT potently inhibited LPS-induced complement activation in the posterior segment of the eye. This study provides insights into the dynamic profile of ocular complement activation, which is valuable for complement research in eye diseases and for developing complement therapeutics for AMD.
引用
- Crowley MA, Delgado O, Will-Orrego A, et al. Induction of Ocular Complement Activation by Inflammatory Stimuli and Intraocular Inhibition of Complement Factor D in Animal Models. Invest Ophthalmol Vis Sci. 2018. PMID: 29450541. doi:10.1167/iovs.17-22605
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。